Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.79%83.270.9%$976.48m
KITEKite Pharma, Inc.
-0.05%179.3016.1%$742.08m
CELGCelgene Corporation
0.08%143.891.1%$497.73m
AMGNAmgen Inc.
-0.47%185.761.1%$483.16m
BIIBBiogen Inc.
1.09%318.461.2%$422.36m
REGNRegeneron Pharmaceuticals, Inc.
-0.17%432.722.7%$354.34m
ALNYAlnylam Pharmaceuticals, Inc
0.78%113.8010.7%$245.72m
JUNOJuno Therapeutics, Inc.
8.46%45.1414.6%$236.75m
ALXNAlexion Pharmaceuticals, Inc.
-0.07%142.821.9%$228.97m
VRTXVertex Pharmaceuticals Incorporated
-0.53%151.261.9%$211.37m
INCYIncyte Corporation
-3.65%110.852.6%$207.65m
ILMNIllumina, Inc.
0.58%201.413.5%$159.41m
BLUEBluebird Bio, Inc.
0.70%128.7519.3%$141.45m
BMRNBioMarin Pharmaceutical Inc.
1.64%94.954.4%$137.39m
CLVSClovis Oncology, Inc.
2.09%78.5618.0%$136.44m

Company Profile

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.